Author Archives: Yves Smith

The Decline in Market Liquidity

While the Fed isn’t worried about the fall in market liquidity, experts argue that if investors make abrupt changes in their portfolios, the lack of liquidity could produce a crisis.

Read more...

Clinical Trial Transparency Effort Encounters Deafening Silence in US Launch; Agnotology or Anechoic Effect?

A successful initiative in the UK to obtain more registration and publication of clinical trial data has had its US launch utterly ignored , not simply the mainstream media but also the logical suspects in the medical trade press and scholarly journals..

Read more...

Bill Black: Republican Candidates Agree that the System is Rigged for the Rich

The Republican candidates for President all made shameless appeals for even more plutocracy, in particular preferential treatment for the rich.

Read more...

Media Hypes Praluent, the Next Expensive “Blockbuster” Not Yet Shown to Benefit Patients

Another example of the corruption of science: the press falls all over itself hyping Praluent, a new cholesterol-lowering drug with remarkably inconclusive clinical trial data behind it. As Roy Poses points out, “The clinical benefit of the drug was not evident in this trial.”

Read more...